{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:18:27Z","timestamp":1761895107358},"reference-count":21,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.jns.2010.05.008","type":"journal-article","created":{"date-parts":[[2010,6,18]],"date-time":"2010-06-18T08:41:40Z","timestamp":1276850500000},"page":"120-124","source":"Crossref","is-referenced-by-count":13,"title":["Lethal giant cell arteritis with multiple ischemic strokes despite aggressive immunosuppressive therapy"],"prefix":"10.1016","volume":"295","author":[{"given":"Christine","family":"Lu-Emerson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand R.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basavaraj","family":"Ghodke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"W.T.","family":"Longstreth,","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep P.","family":"Khot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jns.2010.05.008_bib1","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1212\/WNL.38.3.352","article-title":"Neurologic disease in biopsy-proven giant cell (temporal) arteritis","volume":"38","author":"Caselli","year":"1988","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2010.05.008_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-200301000-00001","article-title":"Bilateral vertebral artery occlusion resulting from giant cell arteritis: report of 3 cases and review of the literature","volume":"82","author":"Ruegg","year":"2003","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.jns.2010.05.008_bib3","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/art.22359","article-title":"Giant cell arteritis: involvement of intracranial arteries","volume":"55","author":"Salvarani","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.jns.2010.05.008_bib4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archneur.1972.00490170010003","article-title":"Arteries of the head and neck in giant cell arteritis. A pathological study to show the pattern of arterial involvement","volume":"27","author":"Wilkinson","year":"1972","journal-title":"Arch. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2010.05.008_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/MD.0b013e3181908e96","article-title":"Stroke and multi-infarct dementia as presenting symptoms of giant cell arteritis: report of 7 cases and review of the literature","volume":"87","author":"Solans-Laque","year":"2008","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.jns.2010.05.008_bib6","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0002-9440(10)64458-6","article-title":"Trapping of misdirected dendritic cells in the granulomatous lesions of giant cell arteritis","volume":"161","author":"Krupa","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.jns.2010.05.008_bib7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7326\/0003-4819-139-6-200309160-00015","article-title":"Giant-cell arteritis and polymyalgia rheumatica","volume":"139","author":"Weyand","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jns.2010.05.008_bib8","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0167-5273(00)00198-4","article-title":"Pathogenic principles in giant cell arteritis","volume":"75","author":"Weyand","year":"2000","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.jns.2010.05.008_bib9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.0954-6820.1986.tb02778.x","article-title":"Long-term survival in giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study of 90 patients treated with corticosteroids","volume":"220","author":"Andersson","year":"1986","journal-title":"Acta Med. Scand."},{"issue":"2","key":"10.1016\/j.jns.2010.05.008_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0002-9343(97)89458-2","article-title":"Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort","volume":"100","author":"Matteson","year":"1996","journal-title":"Am. J. Med."},{"issue":"8","key":"10.1016\/j.jns.2010.05.008_bib11","first-page":"1181","article-title":"Glucocorticoids in the management of vasculitis\u2014a double edged sword?","volume":"15","author":"Conn","year":"1988","journal-title":"J. Rheumatol."},{"issue":"11","key":"10.1016\/j.jns.2010.05.008_bib12","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7326\/0003-4819-120-11-199406010-00004","article-title":"Takayasu arteritis","volume":"120","author":"Kerr","year":"1994","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.jns.2010.05.008_bib13","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/1529-0131(199804)41:4<623::AID-ART9>3.0.CO;2-6","article-title":"Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis","volume":"41","author":"Kaiser","year":"1998","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jns.2010.05.008_bib14","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0002-9149(91)90845-C","article-title":"Effects of prednisolone therapy on arterial angiographic features in Takayasu's disease","volume":"68","author":"Ishikawa","year":"1991","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.jns.2010.05.008_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780400105","article-title":"Disease patterns and tissue cytokine profiles in giant cell arteritis","volume":"40","author":"Weyand","year":"1997","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.jns.2010.05.008_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cyto.2008.09.004","article-title":"Giant cell arteritis and polymyalgia rheumatica: role of cytokines in the pathogenesis and implications for treatment","volume":"44","author":"Martinez-Taboada","year":"2008","journal-title":"Cytokine"},{"issue":"10","key":"10.1016\/j.jns.2010.05.008_bib17","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.3899\/jrheum.090075","article-title":"Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica","volume":"36","author":"Braun","year":"2009","journal-title":"J. Rheumatol."},{"issue":"7","key":"10.1016\/j.jns.2010.05.008_bib18","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/ard.2005.036533","article-title":"Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis","volume":"64","author":"Bhatia","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.jns.2010.05.008_bib19","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1002\/1529-0131(200112)44:12<2933::AID-ART482>3.0.CO;2-Y","article-title":"Treatment of longstanding active giant cell arteritis with infliximab: report of four cases","volume":"44","author":"Cantini","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.jns.2010.05.008_bib20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10067-005-1115-8","article-title":"Infliximab as monotherapy in giant cell arteritis","volume":"25","author":"Uthman","year":"2006","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jns.2010.05.008_bib21","first-page":"S29","article-title":"The role of disease-modifying antirheumatic drugs in the treatment of giant cell arteritis","volume":"21","author":"Nuenninghoff","year":"2003","journal-title":"Clin. Exp. Rheumatol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X10002091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X10002091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T08:25:57Z","timestamp":1544430357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X10002091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":21,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0022510X10002091"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2010.05.008","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}